about
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionDysregulation of glutathione homeostasis in neurodegenerative diseasesNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewGlutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled studyL-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytesLiposomal Antioxidants for Protection against Oxidant-Induced DamageThe Chemistry of Neurodegeneration: Kinetic Data and Their Implications.Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of TrichotillomaniaGlutathione and its antiaging and antimelanogenic effects.Aminothiol receptors for decorporation of intravenously administered (60)Co in the rat.Phase IIb Study of Intranasal Glutathione in Parkinson's DiseaseMultiple antioxidants in the prevention and treatment of Parkinson's disease.Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers.Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level.Targeting maladaptive glutathione responses in lung disease.Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.Nanomedicine strategies for treatment of secondary spinal cord injury.Lipid metabolism and body composition in Gclm(-/-) mice.OTC Antioxidant Products for the Treatment of Cardiovascular and other Disorders: Popular Myth or Fact?Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover studyRole of GSTM1 in resistance to lung inflammation.A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease.Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathyBioavailability Study of an Innovative Orobuccal Formulation of Glutathione.(R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis.Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.A clinical trial of glutathione supplementation in autism spectrum disordersThe treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione.Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effectsDietary antioxidants (selenium and N-acetylcysteine) modulate paraoxonase 1 (PON1) in PCB 126-exposed rats.Psoriasis Improvement in Patients Using Glutathione-enhancing, Nondenatured Whey Protein Isolate: A Pilot Study.2-Aminobutyric acid modulates glutathione homeostasis in the myocardiumA role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.Antioxidant properties of probiotics and their protective effects in the pathogenesis of radiation-induced enteritis and colitis.Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction.Acrolein scavengers: reactivity, mechanism and impact on health.Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease.N-acetylcysteine supplementation controls total antioxidant capacity, creatine kinase, lactate, and tumor necrotic factor-alpha against oxidative stress induced by graded exercise in sedentary men.Oxidation pathway and exacerbations in COPD: the role of NAC.Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function.
P2860
Q24615952-E9BBFADC-EC37-42A3-8134-AF901B7E8E1DQ26822726-9E2B2F7F-8123-4084-A66B-B0E36DD15957Q28248117-9AB99EF5-D64B-4EF6-8B1D-B8CB0B34C190Q28284274-7BFCC6F9-8354-41E0-90E4-219CC941B459Q28378874-8A36F4A2-1174-4A70-BA41-2270F482782DQ28391211-4C4E9CAD-6A48-43CE-A3A0-608EF580D87EQ30973484-8C898770-8C59-4BA2-8817-1DD29CAB52D7Q33584684-F34492C3-62DC-4AFB-89D6-6F7A044DE6DDQ33627633-E4426EC1-A810-460C-BBE7-0C25263FFF33Q33636633-BFF02733-F73E-4E18-BF8E-EA7C3A4F54EFQ33708918-6056EEBF-395E-46E5-BCAD-1B78958215A2Q33746725-A7CF5CEF-5005-4339-BAB8-EF1C88541D3BQ34211581-1B6066C2-992C-46B4-9A45-19B11BEA4E9FQ34341207-37406A2A-96F9-44DC-922E-CF2BFB35934AQ34574707-597423EE-8BA1-4426-8113-A684AD12CDA4Q35025023-16E4AF18-C037-445E-A158-A4C75755588DQ35063603-C625A9D7-625A-4D31-B54D-B4DF7C33B798Q35581011-F41B05B1-7B82-4AE4-97BF-90BA9B91D7CCQ35688098-DBA4D085-5F43-4049-93C5-999D6DC76D6DQ35952668-2BFBA772-D44B-4857-996C-50430B1152ADQ36162231-8DB79247-E791-49B9-BD99-15B3D314B2F7Q36172557-D4A20939-865C-4EC7-904B-F2B714B3ACBEQ36185380-E32337A1-1E8F-4920-9118-666999CDB13BQ36328964-DAFDD198-20C8-4BA1-8894-B05218288A0FQ36417840-23342FF9-3AE6-4ACC-9ACD-A3B98D70AFC3Q36677933-72EC05A0-5921-49F4-8097-D9D95C56B776Q36771431-F1003E67-74AE-4B30-AB7F-36628E81064FQ37101259-FC0842DA-0294-48EA-B511-2A6A138B7006Q37107518-6001F3E0-CAAC-4DCB-9BA3-8D13C75B00DBQ37161117-A250A979-87B1-410A-BF9E-4AB95C83A748Q37247698-9717E826-F7C8-4CBF-9772-B2E1B61EB8ECQ37402550-11B44429-AA2E-4A7F-8045-DDCFB5F033B9Q37698433-A99AFADA-6F5A-430B-989C-3E4C6165331CQ37772797-E09DF006-80D0-42DB-95C8-54494F15C5EBQ37776434-766D698E-E8A4-462D-844B-C91A87ECA63CQ37895630-5F6993E5-D712-488D-B9D1-584BAF17F923Q38023560-FC089973-F8E2-47D5-ACF2-0FAE14727AFEQ38266821-A6744C7C-9764-4947-A9AC-762492894990Q38633304-2FBD6A06-B57A-45AB-A2DD-11EB39D5DD41Q39154995-99259D83-DD3D-4017-9EF0-3CE2E6D05EB8
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականին հրատարակուած գիտական յօդուած
@hyw
1992 թվականին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The systemic availability of oral glutathione
@ast
The systemic availability of oral glutathione
@en
The systemic availability of oral glutathione
@nl
type
label
The systemic availability of oral glutathione
@ast
The systemic availability of oral glutathione
@en
The systemic availability of oral glutathione
@nl
prefLabel
The systemic availability of oral glutathione
@ast
The systemic availability of oral glutathione
@en
The systemic availability of oral glutathione
@nl
P2093
P3181
P356
P1476
The systemic availability of oral glutathione
@en
P2093
P2888
P3181
P356
10.1007/BF02284971
P407
P577
1992-01-01T00:00:00Z
P6179
1020634579